Fundamental analysis by بورس24 | Bourse24 about Stock تیپیکو on 7/14/2025

#Spars Assembly Pars Daru Company was established in 2007 by Bayer Pharama Iran Company by Bayer Germany as the first branch of a multinational and pharmaceutical company in Iran and was put into operation in year 6. The company's registration capital at the time of its establishment was 3 million Rials The company entered the capital market in year 6 The last increase in the company's capital from 5 million shares to 5 million shares was 2 % of the stock Pars Daru Company is ranked 1 among the stock market for the sale. One shareholder asked about reducing the company's sales trend The CEO of the company said: According to Tipiko, the company's sales policy is based on the company's interests. We meet their requests according to their needs, according to their needs In year 4, we were able to supply the raw materials needed for drug production, in the fiscal year, there were no important and important products in the market that Pars Drug did not produce. The discounts we give to distributors have been due to the lack of liquidity in the company. Another shareholder asked about the exchange rate needed to buy raw materials The company's CEO explained: The products of the company are currently in the currency of 4,000 tomans, but some products are supplied at preferential exchange rate @Bourse24ir